Skip to main content
Cancers logoLink to Cancers
. 2022 Aug 31;14(17):4238. doi: 10.3390/cancers14174238

Correction: Aromokeye, R.; Si, H. Combined Curcumin and Luteolin Synergistically Inhibit Colon Cancer Associated with Notch1 and TGF-β Signaling Pathways in Cultured Cells and Xenograft Mice. Cancers 2022, 14, 3001

Rukayat Aromokeye 1, Hongwei Si 1,*
PMCID: PMC9454886  PMID: 36077878

Error in Figure

In the original publication [1], there was a mistake in Figure 1A as currently published: The Figure 1A was accidentally misused from our other similar study. Although the wrong figure cannot affect the conclusion of this paper, we have to use the correct one for this publication. The corrected Figure 1 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

graphic file with name cancers-14-04238-g001.jpg

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Aromokeye R., Si H. Combined Curcumin and Luteolin Synergistically Inhibit Colon Cancer Associated with Notch1 and TGF-β Signaling Pathways in Cultured Cells and Xenograft Mice. Cancers. 2022;14:3001. doi: 10.3390/cancers14123001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES